Elevance Stock Falls on Medicaid Concerns

Dow Jones07-15

Skittish investors pushed Elevance shares down, as they focused on worries about its Medicaid business.

CEO Gail Boudreaux said the insurer's Medicaid results were roughly what it expected, but the company is leaving the District of Columbia's Medicaid market and plans to exit others over the next year to 18 months. Under questioning from analysts, company officials wouldn't say how extensive those departures will be.

Elevance shares were down 10% Wednesday, while competitors including Centene and Molina also slipped. The industry is under pressure from shrinking enrollment in Affordable Care Act plans and Medicaid.

Elevance is seeing higher spending in areas including autism therapy, emergency-room use, outpatient surgery and specialty drugs.

Elevance's second-quarter earnings beat Wall Street expectations, but its guidance for the full year was raised only modestly. The company reiterated that it expected 2026 to be the "trough year" for its Medicaid business's financial performance.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment